載入...
A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir
Remdesivir (GS-5734), a viral RNA-dependent RNA polymerase (RdRP) inhibitor that can be used to treat a variety of RNA virus infections, is expected to be an effective treatment for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. On May 1, 2020, The U.S. Food and Drug Adminis...
Na minha lista:
| 發表在: | Eur J Med Chem |
|---|---|
| Main Authors: | , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier Masson SAS.
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7834743/ https://ncbi.nlm.nih.gov/pubmed/32563812 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejmech.2020.112527 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|